Supplemental Oxygen Protocol for Hypoxia Delayed Effects

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods do not effectively address the delayed effects of exposure to reduced oxygen partial pressure environments, particularly for individuals with special sensitivities, such as those with pre-existing neurological conditions, as they only treat immediate symptoms and do not provide preventative measures to minimize or eliminate these effects.

Innovation Solution

Administering supplemental oxygen during exposure to reduced oxygen partial pressure environments, such as on flights or at high altitudes, to maintain a target oxygen partial pressure that the individual is accustomed to, thereby minimizing the net differential and mitigating delayed effects like seizures.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If supplemental oxygen is administered only to treat immediate hypoxia symptoms, then immediate hypoxia treatment is effective, but delayed effects such as seizures are not prevented

Engineering Contradiction:
Improveeffectiveness of hypoxia treatmentVSAvoiddelayed effects including seizures
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by administering supplemental oxygen before the delayed effects occur. The method extends oxygen administration beyond the immediate hypoxia episode to include a post-exposure period, preventing seizures and other delayed neurological effects before they manifest. This proactive approach transforms reactive treatment into preventive care.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements continuity of useful action by maintaining supplemental oxygen administration continuously through both the immediate hypoxia episode and the subsequent recovery period. Rather than discontinuing oxygen therapy once acute symptoms resolve, the method sustains oxygen delivery to ensure complete prevention of delayed effects, bridging the gap between acute and subacute phases.

Inventive Principle:
Principle #20Continuity of useful action

2Object-affected harmful factors

If supplemental oxygen is administered for an extended period to prevent delayed effects, then delayed effects are minimized, but oxygen consumption and treatment complexity increase

Engineering Contradiction:
Improvedelayed effects including seizuresVSAvoidoxygen administration protocol
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent applies dynamics by implementing a time-varying oxygen administration protocol that adjusts oxygen delivery based on the temporal phase of exposure. The protocol distinguishes between the acute exposure phase and the post-exposure recovery phase, optimizing oxygen delivery parameters for each phase rather than using a static, one-size-fits-all approach.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent implements periodic action through structured oxygen administration intervals that correspond to different phases of hypoxia exposure. The method uses defined time periods (during exposure and after exposure) with specific oxygen delivery parameters for each period, creating a rhythmic, phase-based treatment pattern that balances effectiveness with resource management.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentEP3568353B1Supplemental oxygen for use in methods for minimizing delayed effects of exposure to reduced oxygen partial pressure
Publication Date: 2022.11.30 MODEL SOFTWARE CORP
  • EP3568353B1 patent drawingFigure 1
  • EP3568353B1 patent drawingFigure 2

AI summary

Described herein are methods which involve minimizing or eliminating the occurrence of delayed negative effects that may arise from exposure to reduced oxygen partial pressure. An amount of supplemental oxygen, which substantially mimics a target oxygen partial pressure, is administered to an individual that is exposed to a reduced oxygen partial pressure environment, to compensate for the reduced oxygen partial pressure. The target partial pressure may be selected such that the individual experiences substantially no change in the oxygen partial pressure. Individuals receiving the supplemental oxygen may be healthy, have special sensitivities, or have a pre-existing neurological condition.